Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
About this item
Full title
Author / Creator
EXSCEL Study Group , Holman, Rury R , Bethel, M. Angelyn , Mentz, Robert J , Thompson, Vivian P , Lokhnygina, Yuliya , Buse, John B , Chan, Juliana C , Choi, Jasmine , Gustavson, Stephanie M , Iqbal, Nayyar , Maggioni, Aldo P , Marso, Steven P , Öhman, Peter , Pagidipati, Neha J , Poulter, Neil , Ramachandran, Ambady , Zinman, Bernard and Hernandez, Adrian F
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
This trial, which compared once-weekly exenatide plus usual care with usual care alone in patients with type 2 diabetes with or without previous cardiovascular disease, showed no significant between-group difference in the rates of major adverse cardiovascular events.
Alternative Titles
Full title
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Authors, Artists and Contributors
Author / Creator
Holman, Rury R
Bethel, M. Angelyn
Mentz, Robert J
Thompson, Vivian P
Lokhnygina, Yuliya
Buse, John B
Chan, Juliana C
Choi, Jasmine
Gustavson, Stephanie M
Iqbal, Nayyar
Maggioni, Aldo P
Marso, Steven P
Öhman, Peter
Pagidipati, Neha J
Poulter, Neil
Ramachandran, Ambady
Zinman, Bernard
Hernandez, Adrian F
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_DiVA_org_uu_343197
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_343197
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1612917
